{"id":1000061,"date":"2026-09-02T16:32:35","date_gmt":"2026-09-02T20:32:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/"},"modified":"2026-09-02T16:32:35","modified_gmt":"2026-09-02T20:32:35","slug":"aura-biosciences-to-participate-in-upcoming-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/","title":{"rendered":"Aura Biosciences to Participate in Upcoming Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOSTON, Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ObuhW8OAe4pHI98m2Wg_fRGVPpkeT1FwAEHM6gabUPJ1VPWqoLd31W69KJPTtq2Ebr8OA10V_HPvep1w5_U51IdnDgSEfIwrX-dJeFLjAxLmggoXCU1zxF1gC5DCWBYZ\" rel=\"nofollow\" target=\"_blank\"><u>Aura Biosciences, Inc.<\/u><\/a> (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that\u00a0Natalie Holles, CEO and President, will participate in the following upcoming investor conference:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026.<br \/><\/strong>Fireside Chat at 2:35 p.m. ET<\/li>\n<\/ul>\n<p>The live webcast of the fireside chat will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mQysACvOY7A0nWCMDpWWGf9ORDlmKg-0HVbr-kjbuV1-l8ZBFoUiNYdOnoc7sZ9wgkdZ8Grqefa5qvABv-Yc0fS64w5xXHBVXNsliOHdgAzhwFbgaWZjzXh6X7iIIRTcFYjCxA0Dg389yAmZhwZFwnvIpSvDoDZPuX3zUK2Rwyp9jaHmGoi6KsyVft643gbzvZlzGJpHBwoenQUWCEcnCBRIf_HpOSEFSpcA_56AoMi33VZbRkz8MX8-4cFOzd3RyBELr9pN1wJgpIG8m3Wsdf9w38il-U2LGAOo4Z3LCit_HEpXgMMvQVj7Ddhe05aoQtUFA3nQrb_tlANV_-_MXusAo5aY5vC6GZzWajbLoTt6tq6oN9T-AgSlqmrJl7Ea86byZAoPNeNgtrb6OQbGAqxF3Xivkdiunb39WjE_3VoNKZKy4hLIf1Z5a_HTjonssVCwdxNRy1xJvtmxsKzthwjXOcG5f1bJ34EnVkkop8QT0KAjc23mqvwAOrVL9cnWI7dqDPidpUexrEGAyJvaWB5GAjvDVp5H2nqXOKqZARpnZJfc44xfB_J1FOLy7uXSfmBNEUqkdDF6K5tsjxeWXg-9Uehk2DyDFd2O_82EjN46aHjuX1K7d2nK3IK-mpkzxQ7fpSmB7xJW36TNMJQDVvbPal5oLnuAArgsYiZahH_8l9ikzjxHYzKhvL1SoLXlB9xPEy9pwnkk1DfncwnfsRN_2BmGlVKGM9zzQ8TGNDXmYeMiVzjdrDPIVHiDsAxvGOqhN19Ebiz52SzkmyRZAiyD59D5CIKn4Efj7K7dKVAM-6SzFW9C_c3hCZ7egO0s_xkXr9FqpoXEzOqXhoMHEPRxITajV7eRudNcXd_7DPV02ByOyA6H-BoXrUi6l_bmAwQ25caWB9lixJU1aEwoIDEoT3QzMQ7gWrks0-eru2bIfHg09HGrVDDxEHum7UUvvi9h3DgCr1ksAOtSQkG199QiOflWztPw5997yjOIhP9bRSwcX4cwiaKCSwGyXo9IYiieT5_I3oAwiSK00l3tDvKehPa5m1TRVx-M9aWsAa8kROC3PPa5xVJrPM95lSnJb-UZ-36YXS9OML9r4vMt05mSxwUDIbtyDal6tRBL9y64v8NRGSzhe5IJxyeALi-SX8I7bdAI6LlksdmYQX4tAYbbC5FGcRTiBdrK6AumU79baHNmX72S3GbaW2ZzoRuBCUIAG1A5AomdB88S67vhqSl-eXBqbwfBUPqPbiDH8E69Pefmicxu-luK_qI6BOuxutJ0vx__7TSdTkFCSN7jvlx21y9QO6gBWot9WvvqnyBY3bneg-ssMhLcBMZNXTJZVi2Dnnkgv8FLY1v5Fjy-ua2KYOi33ht6BhYadZxjd8KtH0oLr_es9VEA-QPn9nJr7WKdDDgNy_MaqPp24WNFdZoJoxBZgnDUXebtpRSxJEW4npFGYA6V7px2XeskFpRzBBt7qddshZlNyfg94esxHlxeXoGMzdVHP-a3bnlYh3MMl2t3DPNAdxyJ5ftKQK0Y6i_NetUIXZhuZclQeSQWvOdrHDn4rRIieAYr38Li8Dg01aY15LcznHTxkesDIB1nwaeWmFlT21w9-EVYef9_TK4LgDqwnUFZTVUz9h2vLBAUKJZL__hyatvNRqO3ECz1VT-o36GpcJaHQcyJkieUwGbJweGuPB_VAcIOYJdjOrVKO-OPJqC3WaNS9YixLpvNVShjod_3ZsxxBBNkoChcElPkgvgYU57zutsUPgCXY0Cxc8JhJJZGkYl0uQSyRlHoHFxNAenUikm8_AFoefdmHvTJCS8V15DL-sY-9zuzkMVJrPhnCrGQd0W0MoWfO46AWfwpbi-LyN_WJpp6pFdRtYwEBrLOOhHUGqhjlygur5COlYinMtE_TY8DYKTwH5MbIHMLOXHprxFrQ9DYt3W0D6GzqCJgqDkgNwh068iU3zOWtqvaAWnrratogvXJR0Xa8g6b4nJmhRL1hEjKHJpVbsFuNkWVjmUsHjOJYR93ri0AUMT1tkArStIrMoj3exXsd4PGtMjY9a6lVOAQt97xrrhLhXcfSD72FWgqnKWuoGWevB49gYXYXruXbKsboAZXJ5HKIJa8g8hCAL5oBWIlln-8sDVWg3mPjE9FrNyKWl2tprHpvEBwZqRfybAKiG-9meqFb-o8FC3qgOm4g1NNiLJPKwUFs6WpP-7rR49UW8Vd78jqYyyDYPSHIK2O2z1JKQ_hiTNf6bxhjlo8I_fCvWMjWbW6dn6GzBETixtx1SAeXR4P4XEgwUsV_AcNsz0pt0fTirTUZhCpIQvap5_s2KLOYk1vW4LcGdrBEGFARyO6QM5QUTvqdh4bQOdSXBa4bfnGKbt32J8faLr9oZ6yru5SULWNSWvvQfE5K5nBRhBN9PFgVaUjFdsKPj-S1zYsRBEBBaa69wwpII1VlqsJa9LTvzCj5PeW6xj4k-HykuUotdG923xteVsjXkaBPdMYytIYtpS6c3TVfOj3dh36TW4Xt0xP0YyFK1yDIONLTfKMYJ0XJ3MO-Jk3N9yaaO7VkhVtkI13qCMWZaPv02CWeEdGOvRn4UFOivwIt0609YZLJLPDZUeUOQ2MX2wj1rZt_4qrbzIlLcNunU3HpQXvPo6iJM4QojXo6WaynBEkJh2hGuzMMg9hbeY93DnA6IPx\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.aurabiosciences.com\/events-and-presentations<\/a>, where a replay of the webcast will be archived for 90 days following the presentation date.<\/p>\n<p>\n        <strong>About Aura Biosciences<\/strong>\n      <\/p>\n<p align=\"justify\">Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for patients living with ocular cancers. Bel-sar represents an entirely novel approach to treating ocular cancers via its dual mechanisms of action of acute tumor necrosis and secondary anti-tumor immune activation. The Phase 3 registration study of bel-sar in early choroidal melanoma, the largest patient segment of uveal melanoma, is fully enrolled, and earlier stage studies in metastases to the choroid and cancers of the ocular surface are ongoing. Aura&#8217;s mission is to improve outcomes for patients living with ocular cancers by delivering a therapy that not only arrests tumor growth but also preserves vision and quality of life.<\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QjwCmJi5polviKtuuL5SXXs8dXhuoPpT_Goa5vcHq3MAKDHVd-M9xj6nFMvZJwHdmJGKDtgMRJoqgrQUTKxlfiCM3rnQsfc1HDWC5YehvJo=\" rel=\"nofollow\" target=\"_blank\"><u>aurabiosciences.com<\/u><\/a>. Follow us on X, @AuraBiosciences, and visit us on LinkedIn.<\/p>\n<p>\n        <strong>Investor and Media Relations Contact:<\/strong>\n      <\/p>\n<p>Alex Dasalla<\/p>\n<p>Head of Investor Relations and Corporate Communications<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s4ykTaBDmAgWUiPWWIx0jzfBbq4ZTtV9gKvb0HK0BAIqSXlaY-oXnCy94mZ1z53TWM7kKdOKthVeYEVpZDKOgnjXrYdBOP0CSgVc-UrTzg4=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>IR@aurabiosciences.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTFlMjA3YjAtYmNiZS00YzM2LThkZmItYWViMjI5NGFhNjFlLTUwMDEyNDI2MC0yMDI2LTA5LTAyLWVu\/tiny\/Aura-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that\u00a0Natalie Holles, CEO and President, will participate in the following upcoming investor conference: Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026.Fireside Chat at 2:35 p.m. ET The live webcast of the fireside chat will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where a replay of the webcast will be archived for 90 days following the presentation date. About Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aura Biosciences to Participate in Upcoming Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000061","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that\u00a0Natalie Holles, CEO and President, will participate in the following upcoming investor conference: Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026.Fireside Chat at 2:35 p.m. ET The live webcast of the fireside chat will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where a replay of the webcast will be archived for 90 days following the presentation date. About Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for &hellip; Continue reading &quot;Aura Biosciences to Participate in Upcoming Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T20:32:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aura Biosciences to Participate in Upcoming Investor Conference\",\"datePublished\":\"2026-09-02T20:32:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/\",\"name\":\"Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\",\"datePublished\":\"2026-09-02T20:32:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aura Biosciences to Participate in Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk","og_description":"BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for patients with ocular cancers, today announced that\u00a0Natalie Holles, CEO and President, will participate in the following upcoming investor conference: Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026.Fireside Chat at 2:35 p.m. ET The live webcast of the fireside chat will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where a replay of the webcast will be archived for 90 days following the presentation date. About Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company developing bel-sar, a potentially transformative, first-in-class therapy for &hellip; Continue reading \"Aura Biosciences to Participate in Upcoming Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T20:32:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aura Biosciences to Participate in Upcoming Investor Conference","datePublished":"2026-09-02T20:32:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/","name":"Aura Biosciences to Participate in Upcoming Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==","datePublished":"2026-09-02T20:32:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTU2MiM3ODEzMDcyIzUwMDEyNDI2MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aura Biosciences to Participate in Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000061"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000061\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}